If it weren’t for parent-driven foundations such as Kids’ Cancer Research, his work towards better treatment and cures would not exist.
(PRWEB) November 21, 2012
In a recent article for WND Diversions, Chuck Norris, famous martial artist and actor, wrote of an important reminder he received from Kids’ Cancer Research Foundation’s founder, Frank Kalman. The reminder is the troubling situation of underfunding for pediatric cancer research – of the millions of dollars raised for cancer research every year, only 1 to 3 percent goes into children’s cancer research. Norris received a letter from Kalman, which told the story of his 12-year-old daughter, Callie.
Callie was diagnosed with neuroblastoma, a cancer that is normally found in infants, in the winter of 2001. Neuroblastoma is extremely difficult to diagnose and its progression is fast – as well as extremely painful. Once Callie was diagnosed, Kalman wrote to Norris, his life was dedicated to keeping her alive. At age 23, she is a survivor, yet still at risk and on chemotherapy today.
Norris wrote that it was through Kalman’s experiences of searching for top cancers facilities and connecting with top medical personnel that inspired him to start the Kids’ Cancer Research Foundation.
Pediatric cancer investigators spend a great deal of time sniffing out funding for their projects, which inevitably takes them away from their research, Norris said. He wrote about how one leading children’s cancer investigator told Kalman that if it weren’t for parent-driven foundations such as Kids’ Cancer Research, his work towards better treatment and cures would not exist.
About Kids Cancer Research Foundation
The mission of the Kids’ Cancer Research Foundation is to provide financial support for research and clinical trials that will cure Neuroblastoma (NB), with an emphasis on non-toxic treatments. Our narrow focus on Neuroblastoma is designed to increase the success of finding a cure. Less than half the infants and toddlers survive to adulthood. While the focus is narrow, the benefits derived will be broad. At the time of this writing, approximately 32 other cancers will benefit from advancements made in Neuroblastoma research. Some of the more commonly known are: breast cancer, kidney cancer, brain cancer, liver cancer, and melanoma. Donations are highly encouraged at http://www.endkidscancer.org/donate.